Press-release for stocks publishing date 2022 - 01

Prices are updated after-hours

therapeutics publishing date : 2022 - 01 - 05

save search

Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson’s and Alzheimer’s
Published: 2022-01-05 (Crawled : 13:27) - alteritytherapeutics.com
ATHE | $2.33 9.39% 8.58% 170K

Health Technology

| -74.32% | O: 26.61% H: 17.14% C: 5.71%
alzheimer parkinson patent granted therapeutics disease neurodegenerative alzheimer’s grant alzheimer's

Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
ATHE | $2.33 9.39% 8.58% 170K

Health Technology

| -73.38% | O: 1.65% H: 5.5% C: 1.97%
conference therapeutics

Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
HOWL | $6.405 -0.54% -0.55% 82K

Professional, Scientific, and T...

| -46.33% | O: -0.75% H: 2.1% C: -0.59%
conference therapeutics

Kintara Therapeutics to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
KTRA | $0.1374 3.54% 3.42% 5.8M

Distribution Services

| -76.24% | O: 0.51% H: 1.76% C: -5.64%
conference therapeutics

Soleno Therapeutics to Participate in the LifeSci Partners 11th Annual Corporate Access Event
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
SLNO | $39.365 -1.93% -1.97% 340K

Health Technology

| 8475.09% | O: 0.41% H: 2.13% C: -4.77%
ces therapeutics

Entrada Therapeutics Announces the Appointment of Jared Cohen, PhD, JD to General Counsel
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
TRDA | $12.54 -2.72% -2.79% 39K

Professional, Scientific, and T...

| -19.44% | O: 0.63% H: 1.55% C: -15.96%
ces therapeutics

NeuBase Therapeutics Appoints Dr. Eric J. Ende to Board of Directors
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -4.34% | O: 3.68% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -5.22% | O: 0.91% H: 0.0% C: 0.0%
NBSE | $0.421 4.52% 21K

Health Technology

| -85.52% | O: 0.34% H: 2.06% C: -10.65%
therapeutics

Medicenna to Participate in Upcoming January 2022 Investor Conferences
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
MDNA | $0.157 -0.32% 1.3M

Health Technology

| -91.56% | O: 1.08% H: 0.82% C: -6.91%
ces conference

SAB Biotherapeutics to Present at 2022 H.C. Wainwright BioConnect Virtual Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
SABS | $4.36 7.54% 730

| -45.7% | O: 2.62% H: 2.26% C: -5.46%
conference therapeutics iot

TCR² Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
TCRR 4 | $1.48 3.38% 3.9M

Health Technology

| -68.44% | O: -5.12% H: 0.0% C: 0.0%
conference therapeutics

Life Biosciences, Leading Developer of Therapeutics for Aging-Related Diseases, Completes $82 Million Series C Financing Round
Published: 2022-01-05 (Crawled : 17:00) - biospace.com/
MACK 4 | $14.72 -0.07% -0.07% 110K

Health Technology

| 282.6% | O: 0.26% H: 0.52% C: -1.3%
AGTC | News | $0.3936 1.23% 0.0%

Health Technology

| -79.92% | O: 1.02% H: 0.51% C: -7.58%
therapeutics disease bioscience

Trevi Therapeutics Announces Clinical Trial Updates for Lead Indications
Published: 2022-01-05 (Crawled : 16:00) - biospace.com/
TRVI | $2.68 -5.97% -6.34% 120K

Health Technology

| 265.99% | O: 1.45% H: 10.13% C: 2.53%
trial therapeutics

F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
FSTX | $7.12 0.0% 0

Health Technology

| 43.74% | O: 1.62% H: 4.37% C: -6.36%
star therapeutics germany collaboration license

Y-mAbs Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-05 (Crawled : 15:00) - biospace.com/
YMAB | $15.26 -0.52% -0.52% 160K

Health Technology

| -7.14% | O: -0.03% H: 1.73% C: -8.39%
health thc conference therapeutics j.p. morgan healthcare conference

Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
Published: 2022-01-05 (Crawled : 15:00) - biospace.com/
OTLC | $0.036 -44.63% 8.4K

Manufacturing

| -76.47% | O: 0.0% H: 4.12% C: -0.88%
trial phase 1 phase 2 phase 3

Inhibikase Therapeutics Highlights 2022 Pipeline Goals and Milestones
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
IKT | $1.64 3.8% 3.66% 62K

Health Technology

| -83.94% | O: -1.83% H: 2.48% C: -6.83%
als therapeutics milestone

NiKang Therapeutics and AVEO Oncology Announce a Clinical Trial Collaboration and Supply Agreement to Evaluate the Combination of NKT2152, a HIF2α Inhibitor, and FOTIVDA® (tivozanib) for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
AVEO | $15.0 0.0% 0

Health Technology

| 188.37% | O: -1.92% H: 0.0% C: -12.16%
nkt2152 fotivda treatment renal trial therapeutics cel collaboration cell carcinoma

DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
WVE | $5.01 -1.38% -1.4% 430K

Health Technology